Furthermore, proteomic analysis of MIR503HG revealed other E3 ubiquitin ligases, such as TRIM4, PJA1 and TRIP12, which have been demonstrated to inhibit tumour progression in breast cancer and NSCLC.46, 47, 48. This evidence concerns the gene TRIP12 and breast cancer.